2012 Gastrointestinal Cancers Symposium | 2012 Gastrointestinal Cancers Symposium | Gastrointestinal Cancers Symposium Daily News

Expert Editorials

Consolidating Treatment Response Following Completion of Systemic Therapy in Patients with Oligometastatic Colorectal Cancer

If successful, integration of these treatment modalities with systemic therapy into standard treatment algorithms may lead to improved outcomes for many patients with metastatic CRC. Full article

Aspirin for the Prevention of Colorectal Cancer: Weighing Benefits against Risks

Understanding the role of relatively inexpensive agents, such as aspirin, for chemoprevention remains a high priority. Full article

Gastric Cancer: Finding the Optimal Approach to Adjuvant Therapy

Given conflicting strategies and results, much study is needed regarding the optimal adjuvant treatment approach for patients with resectable gastric cancer. Full article

Targeting Glucose Metabolism: A New Class of Agents against Liver Cancer

Despite cancer’s extreme genetic heterogeneity, the reliance on glycolysis for energy needs and growth is a common pathway that most cancer cells share. As a result, targeting this pathway for therapeutic means is extremely attractive. Full article

Re-examining the Surgical Variable in Multimodality Clinical Trials for Gastric Cancer

It is clear that surgery alone is not a standard treatment for patients with resectable gastric cancer. Based on conflicting results, it remains unclear as to what the benefits of adjuvant radiation therapy are in the context of extended lymphadenectomy. Full article

Liver Transplantation: an Essential Component of Treatment Paradigms for Hepatobiliary Malignancy

Hepatocellular carcinoma (HCC) is an important cancer that can be successfully treated by removal of the tumor or of the liver. For a select group of patients, namely those with early-stage cancer in the setting of advanced underlying liver disease, liver transplantation results in the best outcomes and in the most potential for cure. Full article

Progress in the Management of Upper Gastrointestinal Malignancies

Cancers of the upper gastrointestinal tract form a heterogeneous group of diseases for which treatment paradigms for localized disease continue to emerge. Controversy persists regarding disease management, and treatment algorithms often depend on individual preference, patient referral patterns, and treatment biases. Full article

Moving the Pancreas Cancer Specialty Forward: When Tissue is the Issue

In an era of increasing precision in making choices of whether to treat and how to treat in other common causes of cancer, investigators who work on pancreatic cancer often find themselves handicapped by inadequate access to tissue. This isn’t a result of an “unwillingness” to share; it’s simply the nature of the disease. Full article

Videos